Organoid biobanks preserve patient-derived 3D cultures for future research. Major biobanks include HUB (Netherlands), Crown Bioscience, and institutional repositories enabling large-scale drug screening.
HUB
Foundation
Hubrecht Organoid Technology biobank with 1000+ characterized lines.
CROWN
Commercial
Crown Bioscience/Indivumed acquisition creates largest commercial biobank.